Monday, October 26, 2026 · Daily editionET --:--:--

Looking for volunteers

Surgical Outcome Of da Vinci Single-port Surgical System In Lung Cancer

NCT07790406 · European Institute of Oncology · Updated 27 Aug 2026

What is being tested
da Vinci Single Port
For
Lung Cancer (NSCLC)
Kind of study
Watches patients without assigning a treatment. No drug phase (a device or procedure study).
Who can join
Ages Not stated. About 50 people. The full rules are on the registry page.
Where
Italy
When
Starts or started 2 Feb 2026, ends Dec 2032. Registered 27 Aug 2026.
Results
None posted yet.

In the researchers' words

Early-stage lung cancer represents a clinical challenge that, when diagnosed promptly, offers high chances of cure through lobectomy and lymphadenectomy. In addition to traditional surgery, robotic techniques have become established and have recently evolved further with the Single-Port system, which allows the procedure to be performed through a single subcostal incision rather than multiple openings between the ribs. This approach reduces invasiveness, postoperative pain, and recovery time, while maintaining the same oncological effectiveness and safety as standard techniques. This is a monocentric and non-profit collection of clinical data, both prospective and retrospective, from patients treated with this method, ensuring data privacy through coded information and compliance with current regulations; the study is independent and non-profit.
ClinicalTrials.gov, NCT07790406

Sites

  • Istituto Europeo di OncologiaMilan, Mi, Italy